Chronic obstructive pulmonary disease Management and Follow up.

1-   Abdulsattar, S.A., Hantera, M.S., Hodeb, H.A.M. et al. Study of blood eosinophils and plasma periostin as biomarkers for response of COPD patients to ICS/LABA treatment. Egypt J Bronchol 18, 81 (2024).

2-   Eissa, S.A., Soliman, Y.M.A., Essawy, T.S. et al. Incidence of pulmonary hypertension in COPD and its relation to inflammatory marker interleukin-1. Egypt J Bronchol 18, 27 (2024).

3-   Elkholy, A.A., Hantera, M.S., Abd-El-Zaher, A.H. et al. Screening of cardiovascular disorders among stable COPD patients. Egypt J Bronchol 19, 148 (2025).

4-   Abdelrheem, Shaimaa S.1,2; Osman, Basma M.3; Mohamed, Gehad A.1; Mohammed, Hasnaa K.1; Darwish, Taher M.4; Mohamed Hussein, Aliae A.R.5; Sayed, Hend M.5; Abdul-Kareem, Ebtsam S.6. Determinants of health-related quality of life in stable chronic obstructive pulmonary disease patients. The Egyptian Journal of Chest Diseases and Tuberculosis 74(2):p 150-157, April-June 2025.

5-   Elias, George M.M.; Helmy, Khaled M.W.; El Embaby, Dalia A.E.. Ultrasonographic assessment of diaphragmatic function and its correlation with chronic obstructive pulmonary disease severity in Ain Shams University Hospitals patients. The Egyptian Journal of Chest Diseases and Tuberculosis 75(1):p 98-108, January-March 2026.